Distribution and Afferent Effects of Transplanted mESCs on Cochlea in Acute and Chronic Neural Hearing Loss Models.
Acute Disease
Afferent Pathways
/ pathology
Animals
Auditory Threshold
/ physiology
Chronic Disease
Cochlea
/ pathology
Disease Models, Animal
Evoked Potentials, Auditory, Brain Stem
/ physiology
Green Fluorescent Proteins
/ metabolism
Hearing Loss, Sensorineural
/ physiopathology
Male
Mice
Mice, Inbred C57BL
Mouse Embryonic Stem Cells
/ transplantation
Neurons
/ pathology
Vesicular Glutamate Transport Protein 1
/ metabolism
Journal
BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173
Informations de publication
Date de publication:
2021
2021
Historique:
received:
25
04
2021
accepted:
11
06
2021
entrez:
12
7
2021
pubmed:
13
7
2021
medline:
23
9
2021
Statut:
epublish
Résumé
Hearing loss is a sensory deprivation that can affect the quality of life. Currently, only rehabilitation devices such as hearing aids and cochlear implants are used, without a definitive cure. However, in chronic hearing-deprived patients, in whom secondary auditory neural degeneration is expected, a relatively poor rehabilitation prognosis is projected. Stem cell therapy for cochlear neural structures would be an easier and feasible strategy compared with cochlear sensory cells. Considering the highly developed cochlear implantation technology, improving cochlear neural health has significant medical and social effects. Stem cell delivery to Rosenthal's canal in an acutely damaged mouse model has been performed and showed cell survival and the possibility of differentiation. The results of stem cell transplantation in chronic auditory neural hearing loss should be evaluated because neural stem cell replacement therapy for chronic (long-term) sensorineural hearing loss is a major target in clinics. In the present study, we established a mouse model that mimicked chronic auditory neural hearing loss (secondary degeneration of auditory neurons after loss of sensory input). Then, mouse embryonic stem cells (mESCs) were transplanted into the scala tympani and survival and distribution of transplanted cells were compared between the acute and chronic auditory neural hearing loss models induced by ouabain or kanamycin (KM), respectively. The mESC survival was similar to the acute model, and perilymphatic distribution of cell aggregates was more predominant in the chronic model. Lastly, the effects of mESC transplantation on neural signal transduction observed in the cochlear nucleus (CN) were compared and a statistical increase was observed in the chronic model compared with other models. These results indicated that after transplantation, mESCs survived in the cochlea and increased the neural signaling toward the central auditory pathway, even in the chronic (secondary) hearing loss mouse model.
Identifiants
pubmed: 34250085
doi: 10.1155/2021/4956404
pmc: PMC8238572
doi:
Substances chimiques
Slc17a7 protein, mouse
0
Vesicular Glutamate Transport Protein 1
0
Green Fluorescent Proteins
147336-22-9
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4956404Informations de copyright
Copyright © 2021 So-Young Chang et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
J Assoc Res Otolaryngol. 2002 Sep;3(3):223-33
pubmed: 12382099
PLoS One. 2017 Jul 3;12(7):e0180427
pubmed: 28672008
Neurosurgery. 2004 Nov;55(5):1185-93
pubmed: 15509325
Lancet Neurol. 2002 Jun;1(2):92-100
pubmed: 12849513
Hear Res. 2008 Aug;242(1-2):110-6
pubmed: 18585449
Hear Res. 2017 Mar;345:79-87
pubmed: 28087418
Sci Rep. 2017 Apr 07;7:46058
pubmed: 28387239
J Assoc Res Otolaryngol. 2008 Jun;9(2):225-40
pubmed: 18449604
Biomed Res Int. 2018 Mar 1;2018:9158187
pubmed: 29687008
Stem Cell Rev Rep. 2020 Feb;16(1):3-32
pubmed: 31760627
Biores Open Access. 2014 Aug 1;3(4):162-75
pubmed: 25126480
Hear Res. 2015 Apr;322:77-88
pubmed: 25261772
Stem Cells Dev. 2014 Jun 1;23(11):1275-84
pubmed: 24512547
Spine (Phila Pa 1976). 2010 Jul 15;35(16):1520-6
pubmed: 20581748
Exp Neurol. 2006 Mar;198(1):54-64
pubmed: 16336965
JAMA Otolaryngol Head Neck Surg. 2018 Feb 1;144(2):115-126
pubmed: 29222544
J Assoc Res Otolaryngol. 2005 Mar;6(1):63-74
pubmed: 15735933
PLoS One. 2016 Sep 08;11(9):e0162508
pubmed: 27607106
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13495-500
pubmed: 14593207
Otolaryngol Clin North Am. 2020 Feb;53(1):87-102
pubmed: 31677740
Nature. 2012 Oct 11;490(7419):278-82
pubmed: 22972191
Nat Protoc. 2014;9(6):1229-44
pubmed: 24784820
Lasers Med Sci. 2021 Feb 18;:
pubmed: 33604771